(Q37783421)

23 August 2017

title

Indoxyl sulfate is a nephro-vascular toxin (English)

1 reference

23 August 2017

Indoxyl Sulfate Is a Nephro-Vascular Toxin (English)

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

2 July 2024

author name string

Toshimitsu Niwa

1

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20797565

2 July 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1051227610001135?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

https://api.elsevier.com/content/article/PII:S1051227610001135?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Journal of Renal Nutrition

2 July 2024

published in

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

5 Suppl

1 reference

23 August 2017

page(s)

S2-6

1 reference

Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis

23 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate

2 July 2024

3

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis

2 July 2024

8

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure.

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Oral adsorbent ameliorates renal TGF-beta 1 expression in hypercholesterolemic rats

2 July 2024

15

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Preventive effects of an oral sorbent on nephropathy in rats

2 July 2024

16

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta(1) expression in spontaneously diabetic (OLETF) rats

2 July 2024

17

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats

2 July 2024

19

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD

2 July 2024

23

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure

2 July 2024

24

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects

2 July 2024

25

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells

2 July 2024

26

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate induces complex redox alterations in mesangial cells

2 July 2024

27

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats

2 July 2024

28

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease

2 July 2024

29

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Oral sorbent AST-120 increases renal NO synthesis in uremic rats

2 July 2024

30

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity

2 July 2024

31

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Interactions of human organic anion as well as cation transporters with indoxyl sulfate

2 July 2024

32

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure

2 July 2024

33

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair

2 July 2024

34

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells.

2 July 2024

35

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate promotes proliferation of human aortic smooth muscle cells by inducing oxidative stress.

2 July 2024

36

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.

2 July 2024

37

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats

2 July 2024

38

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells.

2 July 2024

39

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells

2 July 2024

40

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure

2 July 2024

41

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy

2 July 2024

42

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure

2 July 2024

43

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients

2 July 2024

44

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.

2 July 2024

45

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.

2 July 2024

46

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

Uremic toxicity of indoxyl sulfate

2 July 2024

47

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.002

2 July 2024

Identifiers

1 reference

23 August 2017

1 reference